Anaplastic lymphoma kinase modulators and methods of use

The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, c...

Full description

Saved in:
Bibliographic Details
Main Authors MANALO, JEAN-CLAIRE L, BUSSENIUS, JOERG, KENNEDY, ABIGAIL R, PETO, CSABA J, DUBENKO, LARISA, KHOURY, RICHARD G, CURTIS, JEFFRY KIMO, BLAZEY, CHARLES M, COSTANZO, SIMONA, KIM, ANGIE I, BOWLES, OWEN JOSEPH, ANAND, NEEL KUMAR, RICE, KENNETH D, TSANG, TSZE H
Format Patent
LanguageEnglish
Published 02.08.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
Bibliography:Application Number: AU20040259012